Addison's Disease in Dogs: ACTH Test, DOCP vs Fludrocortisone
An evidence-based guide on canine hypoadrenocorticism (Addison's disease). Compare DOCP injections vs daily fludrocortisone, understand the ACTH test, and learn to manage Addisonian crises.
Addison’s disease, clinically known as hypoadrenocorticism, is one of the most famous diagnostic traps in small animal medicine. Frequently referred to as "The Great Imitator," its symptoms—lethargy, vomiting, diarrhea, weight loss, and shaking—wax and wane, mimicking common conditions like primary gastroenteritis, chronic kidney disease, or parasite infestation.
Yet, when the disease progresses to its acute stage—the Addisonian crisis—it becomes a high-stakes, life-threatening emergency. The dog presents collapsed, in hypovolemic shock, and with a dangerously low heart rate caused by severe electrolyte imbalances.
Despite its potential for catastrophe, hypoadrenocorticism is also one of the most rewarding endocrine diseases to treat. With appropriate lifelong hormone replacement, an Addisonian dog can live a normal, active life with a standard life expectancy.
This guide integrates primary regulatory data (including the FDA Freedom of Information summaries for Zycortal and Percorten-V), the 2023 AAHA Selected Endocrinopathies Guidelines, and peer-reviewed literature to evaluate the diagnostic pathway, typical versus atypical presentations, the monthly injection vs. daily pill treatment decision, stress-dosing protocols, and typical cost and insurance expectations.
What is Addison's Disease and Why is it Called "The Great Imitator"?
Primary hypoadrenocorticism is characterized by the bilateral destruction of the adrenal cortex, the outer layer of the adrenal glands. This is the physiological opposite of cortisol excess, which requires Cushing's disease testing and trilostane monitoring to diagnose. This destruction is typically immune-mediated, where the body's immune cells destroy the hormone-producing cells of the adrenal gland.
The adrenal cortex is responsible for producing two classes of hormones:
- Glucocorticoids (primarily Cortisol): Cortisol is the body's primary stress hormone. It helps maintain vascular tone, modulates immune responses, regulates glucose metabolism, and stimulates appetite and gastrointestinal mucosal integrity. Without cortisol, a dog cannot cope with minimal physiologic stress, has poor appetite, is prone to hypoglycemia, and suffers from chronic gastrointestinal inflammation.
- Mineralocorticoids (primarily Aldosterone): Aldosterone is the regulator of blood volume and electrolytes. It acts on the kidneys to promote sodium reabsorption and potassium excretion. Without aldosterone, the body cannot retain sodium and water, leading to severe dehydration, hypovolemia, and hyperkalemia (high blood potassium).
Because cortisol is required for everyday gastrointestinal health, a deficiency causes vague, intermittent symptoms. The dog may have soft stool or vomit after a car ride, a trip to the groomer, or when guests visit the house. The symptoms often improve rapidly with supportive care (such as IV fluids administered at a clinic) only to reappear weeks later. This cycling of illness and temporary recovery is what makes Addison's "The Great Imitator" and frequently delays diagnosis until a major crisis occurs.
The Addisonian Crisis: What It Looks Like and Why It Is an Emergency
An Addisonian crisis represents a state of acute circulatory collapse. It is a true veterinary emergency. It occurs when a dog with undiagnosed or poorly managed hypoadrenocorticism is exposed to a stressor that exceeds its physiological capacity, or when aldosterone levels drop low enough to cause severe electrolyte derangements.
Clinical Presentation of a Crisis
- Severe Hypovolemic Shock: The dog is extremely dehydrated, collapsed, cold, and has weak peripheral pulses and pale, dry mucous membranes with a prolonged capillary refill time (CRT).
- Bradycardia (Slow Heart Rate): Normally, a dog in hypovolemic shock is tachycardic (heart rate > 140–160 bpm) as the heart pumps faster to maintain blood pressure. However, in an Addisonian crisis, the high potassium levels (hyperkalemia) impair the electrical conduction of the heart, resulting in bradycardia (heart rate < 60–80 bpm). Finding a collapsed, severely dehydrated dog with a slow, weak heart rate is a classic indicator of an Addisonian crisis.
- Gastrointestinal Hemorrhage: Severe, blood-tinged diarrhea or vomiting, caused by the collapse of the gastrointestinal mucosal barrier due to a lack of cortisol.
The Immediate Treatment Traps
1. The Corticosteroid Diagnostic Interference
When a collapsed dog enters the ER, the immediate instinct is to administer a rapid-acting steroid like dexamethasone or prednisone. However, administering prednisone, prednisolone, or hydrocortisone before performing the ACTH stimulation test will invalidate the test results. These synthetic glucocorticoids cross-react with the laboratory assays used to measure cortisol, yielding false-positive or uninterpretable results.
- The Solution: If a steroid must be given before the ACTH stimulation test can be completed, dexamethasone (0.15–0.2 mg/kg IV) must be used. Dexamethasone does not cross-react in the cortisol assay, allowing the diagnostic test to be run accurately even after administration.
2. The Insulin-Hypoglycemia Trap
Hyperkalemia is cardiotoxic and must be addressed quickly. One common treatment is administering regular insulin (0.5 U/kg IV) alongside dextrose to drive potassium back into the cells. However, hypoglycemia occurs in up to 38% of Addisonian dogs at presentation due to the lack of cortisol-mediated gluconeogenesis. Administering insulin without confirming normoglycemia can induce fatal hypoglycemic seizures. Insulin should be withheld or administered with extreme caution, always accompanied by a continuous dextrose infusion and frequent blood glucose checks.
How Addison's is Diagnosed: The ACTH Stimulation Test and the Baseline-Cortisol Shortcut
Diagnosing Addison's disease requires demonstrating that the adrenal glands cannot produce cortisol in response to stimulation. The diagnostic pathway is structured to minimize unnecessary testing and expense while ensuring high accuracy.
[ SUSPECTED ADDISONIAN DOG ]
(Vague GI signs, crisis)
│
▼
[ MEASURE BASELINE CORTISOL ]
│
┌────────────────────────┴────────────────────────┐
▼ ▼
[ CORTISOL > 2.0 μg/dL ] [ CORTISOL ≤ 2.0 μg/dL ]
(Addison's is ruled out; search (ACTH Stimulation Test is
for other differential diagnoses) required to confirm)
│
▼
[ ACTH STIMULATION TEST ]
- Draw pre-ACTH blood sample
- Administer Cortrosyn (5 μg/kg IV)
- Draw post-ACTH sample at 1 hour
│
┌─────────────────────────┴─────────────────────────┐
▼ ▼
[ POST-ACTH CORTISOL < 2.0 μg/dL ] [ POST-ACTH CORTISOL ≥ 2.0 μg/dL ]
(ADDISON'S IS CONFIRMED) (ADDISON'S IS RULED OUT; suspect
non-adrenal illness or atypical cases)
The Baseline Cortisol Screen
Because the definitive diagnostic test (ACTH stimulation) requires synthetic hormones that are expensive and occasionally subject to manufacturing shortages, a baseline cortisol screening is recommended.
- The Rule: According to the 2023 AAHA Selected Endocrinopathies Guidelines, a baseline (resting) cortisol value greater than 2.0 μg/dL rules out hypoadrenocorticism with near 100% negative predictive value. If the baseline cortisol is > 2.0 μg/dL, the dog does not have Addison's, and further workup for adrenal insufficiency is unnecessary.
- If the baseline cortisol is less than or equal to 2.0 μg/dL, hypoadrenocorticism cannot be ruled out, and an ACTH stimulation test must be performed.
The ACTH Stimulation Test Protocol
- Pre-Sample: Draw a baseline blood sample to measure pre-ACTH cortisol.
- Administration: Inject synthetic ACTH (cosyntropin or Cortrosyn) at 5 μg/kg IV (or a standard vial dose of 250 μg/dog for dogs over 5 kg).
- Post-Sample: Draw a second blood sample exactly 1 hour after the injection.
- Interpretation:
- A post-ACTH cortisol value less than 2.0 μg/dL (55 nmol/L) is diagnostic for hypoadrenocorticism.
- A post-ACTH cortisol value between 2.0 and 5.0 μg/dL is equivocal, often representing early disease or drug-induced suppression.
- A post-ACTH cortisol value greater than 5.0 μg/dL rules out hypoadrenocorticism.
Common Laboratory Abnormalities and Diagnostic Traps
While the ACTH stimulation test is the gold standard for diagnosis, complete blood counts (CBC) and serum biochemistry panels reveal other characteristic abnormalities that should raise clinical suspicion:
- The Absence of a Stress Leukogram: A sick, collapsed, or shocked dog with normal adrenal function will release endogenous cortisol, leading to a "stress leukogram" characterized by lymphopenia, eosinopenia, and neutrophilia. In contrast, an Addisonian dog in crisis lacks cortisol. Consequently, finding a critically ill dog with a normal or elevated lymphocyte count (lymphocytosis) or a normal or elevated eosinophil count (eosinophilia) is a major diagnostic red flag. The lack of a stress leukogram in a highly stressed patient should always prompt a workup for hypoadrenocorticism.
- Anemia of Inflammatory/Adrenal Disease: Up to 30% of Addisonian dogs present with a mild-to-moderate, non-regenerative, normocytic, normochromic anemia. This is caused by the lack of cortisol's stimulatory effects on the bone marrow, as well as chronic gastrointestinal blood loss. At initial presentation, this anemia may be masked by hemoconcentration due to severe dehydration. Once the dog is rehydrated with IV fluids, the hematocrit will drop, revealing the underlying anemia.
- Azotemia and Hyposthenuria: Severe dehydration and hypovolemia lead to pre-renal azotemia (elevated BUN and creatinine). Typically, pre-renal azotemia is accompanied by highly concentrated urine (Urine Specific Gravity or USG > 1.030). However, because mineralocorticoid deficiency causes chronic sodium wasting in the kidneys, the renal medullary concentration gradient is washed out. As a result, Addisonian dogs often present with pre-renal azotemia but a low USG (< 1.030, often in the isosthenuric range of 1.008–1.012). This can mimic primary renal failure, creating a significant diagnostic trap. Pre-renal azotemia that resolves rapidly with IV fluid therapy within 24 to 48 hours is highly suggestive of Addison's rather than chronic kidney disease.
Typical vs. Atypical Addison's (And Why Normal Electrolytes Do Not Rule It Out)
Veterinarians classify hypoadrenocorticism into two clinical forms based on which layers of the adrenal cortex are damaged:
1. Typical Addison's Disease
This represents the classic form, where both glucocorticoid and mineralocorticoid production are lost. Because aldosterone is missing, these dogs show classic electrolyte changes: low sodium (hyponatremia), high potassium (hyperkalemia), and a sodium-to-potassium ratio (Na/K ratio) of less than 27:1 (and often less than 24:1). These dogs suffer from chronic dehydration, cardiac arrhythmias, and are prone to acute crises.
2. Atypical Addison's Disease
Atypical hypoadrenocorticism occurs when only glucocorticoid production is lost, while mineralocorticoid (aldosterone) production remains normal. This should not be confused with iatrogenic Addison's from trilostane, which is caused by medication oversuppression rather than autoimmune destruction.
- The Diagnostic Trap: Because aldosterone is normal, these dogs have completely normal sodium and potassium levels. General blood panels show no electrolyte abnormalities. If a clinician relies solely on the Na/K ratio to screen for Addison's, they will miss atypical cases.
- Clinical Features: Atypical Addisonian dogs present with chronic, waxing-and-waning gastrointestinal signs (weight loss, vomiting, hypoalbuminemia) and lethargy. They are typically diagnosed at an older age (median 6–7 years) compared to typical cases (median 4–5 years).
- Progression: A subset of atypical cases will eventually progress to typical Addison's as the immune-mediated destruction spreads to the mineralocorticoid-producing layer of the cortex. Therefore, electrolyte levels must be rechecked periodically (every 3 to 6 months) in all atypical dogs.
DOCP vs. Fludrocortisone: Monthly Shot vs. Daily Pill
Managing typical Addison's disease requires replacing the missing hormones. Glucocorticoids are replaced with low-dose oral prednisone, while mineralocorticoids are replaced using one of two primary therapeutic strategies.
Option 1: Desoxycorticosterone Pivalate (DOCP) Injections (Zycortal or Percorten-V)
DOCP is a long-acting ester of desoxycorticosterone that acts as a pure mineralocorticoid. It is administered as a subcutaneous or intramuscular injection once every 25 to 30 days.
- Efficacy: DOCP is highly effective at controlling electrolytes and suppressing plasma renin activity. In the 180-day field study for Zycortal (NADA 141-444), success rates were 86.2% on Day 90 and 88.3% on Day 180, with a mean final dose of 1.9 mg/kg and a mean injection interval of 38.5 days.
- Glucocorticoid Requirement: Because DOCP has zero glucocorticoid activity, every dog receiving DOCP must also receive daily low-dose oral prednisone or prednisolone (0.1–0.2 mg/kg/day).
- The Zycortal Na/K-Ratio Dosing Table: The initial starting dose is 2.2 mg/kg. At Day 10 (peak effect) and Day 25 (trough effect), electrolytes are checked. The next dose is adjusted based on the Day 25 Na/K ratio:
| Day 25 Na/K Ratio | Action / Dose Adjustment |
|---|---|
| Ratio > 34 | Prolong the injection interval (e.g., check electrolytes again at Day 32) or decrease the dose by 10%. |
| Ratio 32 to 34 | Maintain the current dose and interval (usually 28 days). |
| Ratio 27 to 32 | Increase the dose by 10–20% or shorten the injection interval to 25 days. |
| Ratio < 27 | Severe mineralocorticoid deficiency. Increase the dose by 20–25% and ensure the dog is stabilized. |
- Low-Dose Protocols (The Clinical Reality): While the official FDA-approved label specifies a starting dose of 2.2 mg/kg, multiple prospective studies (including PMC6524388) have shown that a low-dose protocol of 1.5 mg/kg DOCP is highly effective in stabilizing electrolytes. Furthermore, a 2025 international veterinary survey reported a median long-term maintenance dose of only 0.88 mg/kg q28d, which significantly reduces the monthly cost for owners of large-breed dogs.
Option 2: Fludrocortisone Acetate (Florinef)
Fludrocortisone is a daily oral pill that possesses both mineralocorticoid and glucocorticoid activity.
- Efficacy: It is convenient because it is oral and avoids monthly clinic visits. However, it is less potent at mineralocorticoid replacement than DOCP.
- The Glucocorticoid Excess Trap: Because fludrocortisone contains significant glucocorticoid activity, as the dose is escalated to control potassium, the glucocorticoid component can cause side effects. Dogs often develop severe polyuria and polydipsia (PU/PD), urinary incontinence, panting, and muscle wasting (classic Cushingoid signs). For details on managing these risks, see our guide on corticosteroid side effects in dogs and cats.
- The Cost Trap: For large dogs (e.g., Standard Poodles), the daily pill count can be high (often 5 to 10 tablets daily), making fludrocortisone far more expensive than low-dose monthly DOCP injections.
DOCP vs. Fludrocortisone Comparison
| Metric | DOCP (Zycortal / Percorten-V) | Fludrocortisone (Florinef) |
|---|---|---|
| Route | Subcutaneous or Intramuscular Injection | Oral Pill (daily or twice daily) |
| Frequency | Once every 25–30 days | Daily, ongoing |
| Mineralocorticoid Potency | High; excellent control of sodium and potassium. | Moderate; requires frequent dose adjustments. |
| Glucocorticoid Component | None; requires daily prednisone pills. | High; often does not require additional prednisone. |
| Side Effects | Minimal; related to the concurrent prednisone dose. | High risk of steroid side effects (PU/PD, panting, incontinence). |
| Outpatient Monitoring | Electrolytes checked at Day 10 and Day 25 initially, then every 3–6 months. | Electrolytes checked weekly initially, then monthly. |
| Suitability for Large Dogs | Excellent (highly cost-effective with low-dose protocols). | Poor (pill burden and cost become prohibitive). |
Steroid Replacement, Stress Dosing, and the Monitoring Schedule
Successfully managing an Addisonian dog requires careful adjustment of their daily glucocorticoid dose.
The Baseline Prednisone Dose
The typical maintenance dose of prednisone or prednisolone is 0.1–0.2 mg/kg/day PO. The goal is to use the lowest effective dose that prevents vomiting, diarrhea, and lethargy without causing steroid side effects.
The "Stress Dosing" Rule
Under normal conditions, a dog's adrenal glands produce extra cortisol in response to stress (excitement, travel, veterinary visits, boarding, illness, or surgery). Because Addisonian dogs cannot produce this hormone, they will slide into a crisis if their dose is not increased during these events.
- The Protocol: For minor stress (grooming, travel, boarding), increase the prednisone dose to 2 to 3 times the baseline maintenance dose starting the day before the event and continuing for 1 to 2 days after.
- For Major Stress (Surgery or Illness): Under veterinary supervision, the dose may be increased to 5 to 10 times the baseline maintenance dose or transitioned to intravenous dexamethasone during procedures.
Outpatient Monitoring Schedule
- Initial Phase (Month 1): Check electrolytes at Day 10 (peak DOCP effect) and Day 25 (trough effect) to determine the next dose and interval.
- Stabilization Phase (Months 2–3): Recheck electrolytes at Day 25 after any dose adjustment.
- Maintenance Phase (Ongoing): Once stabilized, check electrolytes and run a chemistry panel every 3 to 6 months to monitor kidney function, liver values, and electrolyte stability.
Breeds, Signalment, and Who Gets Addison's
Addison’s disease is primarily a disease of young to middle-aged dogs, with a median age of presentation of 4 to 5 years. Along with diabetes in dogs, it represents one of the most common lifelong endocrine disorders requiring careful clinical monitoring.
- Sex Predisposition: There is a distinct female predisposition: approximately 70% of Addisonian dogs are female. Atypical cases are slightly more balanced, with roughly 55% females.
- Breed Predispositions:
- Standard Poodles: Highly overrepresented; up to 8.6% of Standard Poodles are affected in some bloodlines.
- Nova Scotia Duck Tolling Retrievers: 1.4% prevalence in genetic registries.
- Portuguese Water Dogs: High incidence.
- Bearded Collies: Notable predisposition.
- Great Danes, West Highland White Terriers, and Soft Coated Wheaten Terriers also show elevated risk.
- Genetics: Spontaneous primary hypoadrenocorticism is inherited as an autosomal recessive trait in the Standard Poodle, Portuguese Water Dog, and Nova Scotia Duck Tolling Retriever.
What Addison's Costs: Diagnosis, Monthly Treatment, and Pet-Insurance Logic
Managing Addison's is a long-term financial commitment. While the drugs themselves are not prohibitively expensive, the diagnostic workup, crisis stabilization, and frequent monitoring add up.
Expected Cost Breakdown
| Phase / Service | Estimated Cost | Details |
|---|---|---|
| Diagnostic Phase | $500 – $1,500 | Emergency clinic exam, baseline blood panels, resting cortisol, ACTH stimulation test, abdominal ultrasound (to measure adrenal gland size). |
| Crisis Stabilization (If Needed) | $1,500 – $4,000 | 24–48 hours of ICU hospitalization, IV fluid therapy, electrolyte monitoring, ECG, intravenous dexamethasone. |
| Monthly Maintenance (Typical Dog, 20 kg) | $50 – $120 / month | Monthly DOCP injection (dosed at 1.0–1.5 mg/kg) plus daily oral prednisone. |
| Outpatient Monitoring (Annual) | $400 – $800 / year | Electrolyte checks and chemistry panels every 3 to 6 months. |
Pet Insurance and Pre-Existing Conditions
Because Addison's is a lifelong, chronic condition, pet insurance will only cover the costs if the policy was active before the dog showed any clinical signs or received a diagnosis.
- If the policy was active beforehand, typical accident-and-illness coverage will reimburse 70% to 90% of the diagnostics, crisis hospitalization, monthly DOCP, and monitoring tests.
- If a dog has had "vague GI signs" or "unexplained vomiting" documented in their medical records prior to the insurance policy's waiting period, the insurer will likely deny all subsequent Addison's claims, classifying it as a pre-existing condition.
- Owners of predisposed breeds (like Standard Poodles) are strongly advised to compare the best pet insurance for dogs and secure coverage early in puppyhood before any gastrointestinal illness is recorded.
FAQs
What is the life expectancy of a dog with Addison's disease?
With appropriate treatment and monitoring, a dog with Addison's disease has a normal life expectancy. Once stabilized on hormone replacement, they can live a full, active, and healthy life.
What are the early symptoms of Addison's in dogs?
Early signs are vague and intermittent. They include lethargy, decreased appetite, vomiting, diarrhea, weight loss, shivering or shaking, and muscle weakness. These symptoms often flare up during times of stress.
Can Addison's disease be cured in dogs?
No. Addison's disease is a lifelong autoimmune condition that cannot be cured. However, it is highly manageable with daily oral medication and monthly injections.
How much does it cost to treat a dog with Addison's?
After the initial diagnosis and stabilization (which can cost $1,500 to $5,000 if the dog was in a crisis), monthly maintenance costs typically range from $50 to $200 per month depending on the dog's size.
Is the monthly DOCP injection better than daily fludrocortisone pills?
Yes, in most cases. DOCP provides superior electrolyte control and renin suppression. Fludrocortisone often requires high doses to control potassium, leading to significant steroid side effects like excessive drinking, urination, and panting. Additionally, daily pills can become more expensive than DOCP for larger dogs.
Sources
- Zycortal FOI Summary: FDA Center for Veterinary Medicine. Zycortal (desoxycortone pivalate) FOI Summary, NADA 141-444 original approval Feb 17 2016.
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/936 - Percorten-V FOI Summary: FDA Center for Veterinary Medicine. Percorten-V FOI Summary, NADA 141-029.
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/3622 - Zycortal Label: DailyMed (NIH/NLM). ZYCORTAL (desoxycortone pivalate injectable suspension) label, Dechra.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c9b766a-c36b-44aa-bbd8-24fab24ca97c - AAHA Guidelines: American Animal Hospital Association. Canine Hypoadrenocorticism Diagnostic Testing and Monitoring. 2023 Selected Endocrinopathies Guidelines.
https://www.aaha.org/resources/2023-aaha-selected-endocrinopathies-of-dogs-and-cats-guidelines/diagnostic-testing-and-monitoring-3 - PMC Management Review: Lathan, P., & Thompson, A. L. (2018). Management of hypoadrenocorticism (Addison's disease) in dogs. Veterinary Medicine: Research and Reports, 9, 1–10.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6055912/ - Low-Dose DOCP Study: Sieber-Ruckstuhl, N. S., et al. (2019). Evaluation of a low-dose desoxycorticosterone pivalate treatment protocol for long-term management of dogs with primary hypoadrenocorticism. Journal of Veterinary Internal Medicine, 33(3), 1266–1271.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6524388 - Today's Veterinary Practice DOCP: Today's Veterinary Practice. Desoxycorticosterone Pivalate for Dogs with Addison's Disease.
https://todaysveterinarypractice.com/pharmacology/desoxycorticosterone-pivalate-for-dogs-with-addisons-disease - Merck Veterinary Manual: Merck Veterinary Manual. Addison Disease (Hypoadrenocorticism) in Animals.
https://www.merckvetmanual.com/endocrine-system/the-adrenal-glands/addison-disease-hypoadrenocorticism-in-animals
